---  
layout: startup_page  
title: "Renalys Pharma"  
id: "renalys.com"  
permalink: "/renalyspharmarenalys.com07172024/"  
website: "https://renalys.com/"  
funding_round: "Series A"  
funding_amount: "¥6.0Bn"  
investors: "Catalys Pacific, SR One, JPS Growth Investment Limited Partnership, Sumitomo Mitsui Trust Bank Co., Ltd., Japan Co-Invest IV Limited Partnership, NVCC NO.9 Investment Limited Partnership"  
about: "Renalys Pharma is a late-stage clinical biopharmaceutical company focused on developing innovative therapeutics to address unmet needs in renal disease management for Japanese and Asian patients. The company obtained the rights to sparsentan, a promising treatment for IgA nephropathy, and is conducting a Phase III clinical trial in Japan. Renalys aims to improve access to new kidney disease treatments in the region."  
markets: "Biopharmaceutical, Healthtech"  
hq: "Tokyo, Japan"  
founded_year: "2023"  
linkedin: ""  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: ""  
pitchbook: "https://pitchbook.com/profiles/company/572009-59"  

date_display: "17-Jul-2024"  
date: "2024-07-17"

# SEO Optimization  
meta_title: "Renalys Pharma - Series A Funding (¥6.0Bn)"  
meta_description: "Renalys Pharma, Renalys Pharma is a late-stage clinical biopharmaceutical company focused on developing innovative therapeutics to address unmet needs in renal diseas..."  
meta_keywords: "Renalys Pharma, Biopharmaceutical, Healthtech, Series A funding"  
canonical_url: "https://startup.projectstartups.com/renalyspharmarenalys.com07172024/"  
---